Paper36948331
Biological activity of algal derived carrageenan: A comprehensive review in light of human health and disease.
Pradhan B and 1 other. Int J Biol Macromol, 2023. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Biological activity of algal derived carrageenan: A comprehensive review in light of human health and disease. Papers, record 36948331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36948331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biological activity of algal derived carrageenan: A comprehensive review in light of human health and disease.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Seaweed | Major topic |
| Humans | |
| Carrageenan | |
| Polysaccharides | |
| Plants | |
| Antioxidants |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42787751 | Seaweed sulfated polysaccharides regulate the gut microbiota-mucosal barrier-innate immunity axis: structural heterogeneity, immunological evidence, and translational prospects. | Front Immunol | 2026 | https://conductscience.org/library/papers/42787751 | PubMed |
| 42560937 | Carrageenan: Food Additive or Health Concern? A Comprehensive Review. | Ann Nutr Metab | 2026 | https://conductscience.org/library/papers/42560937 | PubMed |
| 42431984 | Extraction, characterization, and antimicrobial potential of Kappa-Carrageenan from Kappaphycus alvarezii with HasA-targeted molecular docking validation. | NPJ Sci Food | 2026 | https://conductscience.org/library/papers/42431984 | PubMed |
| 41568226 | Ammonia-triggered disintegration of kappa-carrageenan hydrogel carrier for site-specific anti-inflammatory drug delivery. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/41568226 | PubMed |
| 41295412 | Botryocladia leptopoda Extracts Promote Wound Healing Ability via Antioxidant and Anti-Inflammatory Activities and Regulation of MMP/TIMP Expression. | Mar Drugs | 2025 | https://conductscience.org/library/papers/41295412 | PubMed |
| 41012518 | Liposomal Encapsulation of Pine Green Cone Essential Oil: The Influence of the Carrier on the Enhancement of Anti-Inflammatory Activity. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012518 | PubMed |
| 40854650 | Computational identification of dual COX-1 and NIK inhibitors from marine microalga Chlorella vulgaris. | J Genet Eng Biotechnol | 2025 | https://conductscience.org/library/papers/40854650 | PubMed |
| 40647761 | Polysaccharide-Based Nanocarriers for Natural Antimicrobials: A Review. | Polymers (Basel) | 2025 | https://conductscience.org/library/papers/40647761 | PubMed |
| 40584756 | Carrageenan: structure, properties and applications with special emphasis on food science. | RSC Adv | 2025 | https://conductscience.org/library/papers/40584756 | PubMed |
| 40072612 | The biotechnological and economic potential of macroalgae in the Baltic Sea. | Planta | 2025 | https://conductscience.org/library/papers/40072612 | PubMed |
| 39997715 | Exploring the Antineoplastic Properties of the Lebanese Jania rubens Against Colorectal Cancer. | Metabolites | 2025 | https://conductscience.org/library/papers/39997715 | PubMed |
| 39958265 | Sustainable and biocompatible hybrid materials-based sulfated polysaccharides for biomedical applications: a review. | RSC Adv | 2025 | https://conductscience.org/library/papers/39958265 | PubMed |
| 39678953 | Algae a Potential Source in Cosmetics: Current Status, Challenges, and Economic Implications. | Indian J Microbiol | 2024 | https://conductscience.org/library/papers/39678953 | PubMed |
| 39330232 | Healing Potential of the Marine Polysaccharides Carrageenan and Ulvan on Second-Degree Burns. | J Funct Biomater | 2024 | https://conductscience.org/library/papers/39330232 | PubMed |
| 39195465 | Recent Advances in Marine-Derived Compounds as Potent Antibacterial and Antifungal Agents: A Comprehensive Review. | Mar Drugs | 2024 | https://conductscience.org/library/papers/39195465 | PubMed |
| 39066021 | Piezoelectric Behaviour in Biodegradable Carrageenan and Iron (III) Oxide Based Sensor. | Sensors (Basel) | 2024 | https://conductscience.org/library/papers/39066021 | PubMed |
| 39057449 | Gelatin-Based Scaffolds with Carrageenan and Chitosan for Soft Tissue Regeneration. | Gels | 2024 | https://conductscience.org/library/papers/39057449 | PubMed |
| 38396650 | Structure, Physicochemical Properties and Biological Activity of Lipopolysaccharide from the Rhizospheric Bacterium Ochrobactrum quorumnocens T1Kr02, Containing d-Fucose Residues. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38396650 | PubMed |
| 37896072 | New Perspective for Macroalgae-Based Animal Feeding in the Context of Challenging Sustainable Food Production. | Plants (Basel) | 2023 | https://conductscience.org/library/papers/37896072 | PubMed |
| 37504914 | Algal Phycocolloids: Bioactivities and Pharmaceutical Applications. | Mar Drugs | 2023 | https://conductscience.org/library/papers/37504914 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36948331
GET https://conductscience.org/api/papers/v1/36948331/cited_by?page=2